Phase 2 Clinical Status

Last Update: May 28, 2021

ABBREVIATIONS:

  • ADC: Antibody Drug Conjugate;

  • Ara-A: 9-β-D-arabinofuranosyladenine

  • Ara-C: Cytosine Arabinoside

  • BCMA: B-cell Maturation Antigen

  • CD: Cluster of Differentiation;

  • c-Met: Tyrosine-Protein Kinase Met

  • DMXBA: 3-(2,4-Dimethoxybenzylidene)-Anabaseine

  • EGFR: Epidermal Growth Factor Receptor;

  • ENPP3: Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 3

  • FDA: Food and Drug Administration;

  • GPNMB: Glycoprotein nonmetastatic B;

  • LIV-1: Zinc transporter SLC39A6;

  • LRRC15: Leucine rich repeat containing 15

  • MMAE: Monomethylauristatin E;

  • MMAF: Monomethylauristatin F;

  • NaPi2b: Sodium-Dependent Phosphate Transport Protein 2b;

  • PSMA: Prostate-Specific Membrane Antigen;

  • TIM-1: T-cell Immunoglobulin domain 1